Tuberculosis patient expenditure on drugs and tests in subsidised, public services in China: a descriptive study

Abstract

Despite an ostensibly fully subsidised TB programme in China, patients are charged substantive amounts irrespective of income. Research is needed to confirm these practices are widespread but this needs to be coupled with financing strategies to tackle it.